Story Stocks®
- NKE delivered Q2 revenue of $12.4 bln, an increase of 1% that beat the company's own guidance for a low-single-digit decline.
- North American revenue surged 9% to $5.63 bln, driven by double-digit growth in Running and a 24% increase in the wholesale channel as NKE focuses on "winning on the ground" through its "Win Now" strategy.
- However, Greater China revenue plummeted 16% on a constant-currency basis to $1.4 bln, weighed down by declining store traffic, soft sell-through, and a highly promotional retail environment.
- Also, Direct-to-Consumer (DTC) revenues fell 9% currency-neutral, led by a 14% drop in digital sales as the company deliberately reduced its reliance on high-volume legacy franchises like Dunks, which saw declines of over 20%, to restore brand premiumization.
- Gross margin fell 300 bps to 40.6%, a result that was at the favorable end of management’s prior forecast of a 300–375 bps decline.
- Q3 gross margin is projected to contract by 175–225 bps. Notably, excluding a 315-bps headwind from higher product costs related to new tariffs, margins would have expanded yr/yr.
- For Q3, NKE expects revenue to decline in the low single digits, below the FactSet consensus of roughly 1% growth.
Briefing.com Analyst Insight:
NKE's Q2 performance offers a "good news, bad news" narrative that leaves the market skeptical. On one hand, the "Win Now" strategy is bearing fruit in North America, where a return to wholesale partnerships and a focus on performance running are stabilizing the brand's home turf. On the other hand, the "middle innings" of this comeback look increasingly grueling. China remains a significant drag with no immediate sign of a floor, and the company's aggressive clearing of legacy "classics" is creating a revenue hole that new innovation hasn't yet filled. Furthermore, the looming 315 bps tariff hit in Q3 serves as a stark reminder of the external volatility NKE faces. With the stock trading at a premium P/E multiple of 34x despite stagnant organic growth, we would wait until seeing stronger evidence that a recovery is gaining traction before taking a more aggressive approach with the stock.